Ophthalmic shunt and method

Patent metadata

Field	Value
Publication number	US-9907695-B2
Application number	US-201615008279-A
Country	US
Kind code	B2
Filing date	Jan 27, 2016
Priority date	May 13, 2013
Publication date	Mar 6, 2018
Grant date	Mar 6, 2018

Abstract

An ophthalmic shunt includes a seal or septum through which multiple injections of the therapeutic agent can be made as needed, thereby avoiding repeated injury to the sclera. The therapeutic agent is temporarily carried in a tube connected to the septum. The therapeutic agent release may be rapid or sustained over a period of time.

First claim

What is claimed is:

1. An implantable ophthalmic shunt comprising:
a tube, there being an inlet aperture at an end of the tube; and
a septum covering the inlet aperture of the tube, the septum forming a resilient seal against fluid flow, the septum configured to be pierced by a needle, wherein the septum is made of a material that includes a polymerization initiator that is activated by application of energy to the septum to seal a hole in the septum caused by needle insertion, wherein the polymerization initiator is activated by ultraviolet radiation,
wherein the tube has no outlet aperture for releasing material out of the tube.

2. The implantable ophthalmic shunt of claim 1 , wherein the septum is configured to autonomously close an aperture formed by a needle having pierced the septum and having been withdrawn from the septum.

3. The implantable ophthalmic shunt of claim 1 , wherein the septum is made of a silicone elastomer.

4. The implantable ophthalmic shunt of claim 1 , wherein the polymerization initiator is activated by application of heat, ultraviolet radiation, an electric field, or a combination thereof to the septum.

5. The implantable ophthalmic shunt of claim 1 , wherein the tube is configured to swell or expand with introduction of a therapeutic agent into the tube.

6. The implantable ophthalmic shunt of claim 1 , wherein the tube has a cavity containing a composition including a therapeutic agent.

7. The implantable ophthalmic shunt of claim 6 , wherein the composition further includes any of an excipient, hydrophobic polymer, hydrogel, and a combination of two or more thereof.

8. The implantable ophthalmic shunt of claim 6 , wherein the tube is made of a permeable material through which the therapeutic agent permeates.

9. The implantable ophthalmic shunt of claim 1 , further comprising a coating over an outer surface of the tube.

10. The implantable ophthalmic shunt of claim 9 , wherein the coating is configured to adhere to eye tissue.

11. The implantable ophthalmic shunt of claim 9 , wherein the coating includes a substance selected from the group consisting of an antibiotic, silver ions, extracellular matrix material, and a combination of two or more thereof.

12. The implantable ophthalmic shunt of claim 9 , wherein the coating includes one or both of cross-linked polyethylene glycol and polylactide-co-glycolide.

13. The implantable ophthalmic shunt of claim 1 , further comprising a ring disposed between a proximal end of the tube and a distal end of the tube, the ring extending circumferentially around an exterior surface of the tube and protruding radially outward from the exterior surface.

14. The implantable ophthalmic shunt of claim 1 , wherein the septum protrudes radially outward from the tube.

15. The implantable ophthalmic shunt of claim 1 , further comprising a balloon attached to the tube.

16. The implantable ophthalmic shunt of claim 1 , wherein the tube includes an interior passageway, and a stop feature within the tube constricts the interior passageway to block passage of a needle.

17. A method comprising:
introducing a therapeutic agent through a septum covering an inlet aperture formed at an end of a tube of an ophthalmic shunt implanted through the sclera of an eye, wherein the tube has no outlet aperture for releasing material out of the tube; and
allowing the therapeutic agent to permeate through the tube and into the eye,
wherein introducing the therapeutic agent through the septum includes piercing the septum with a needle and injecting the therapeutic agent through the needle,
after piercing the septum with the needle, activating a polymerization initiator in the septum to seal a hole formed by the needle in the septum,
wherein activating the polymerization initiator includes applying ultraviolet radiation to the septum to seal a hole formed by the needle in the septum.

18. The method of claim 17 , wherein the piercing of the septum with the needle includes moving the needle through an interior passageway of the tube, and the movement of the needle through an interior passageway is limited by a constriction in the interior passageway.

19. An implantable ophthalmic shunt comprising:
a tube, there being an inlet aperture at an end of the tube; and
a septum covering the inlet aperture of the tube, the septum forming a resilient seal against fluid flow, the septum configured to be pierced by a needle, wherein the septum is made of a material that includes a polymerization initiator that is activated by application of energy to the septum to seal a hole in the septum caused by needle insertion, wherein the polymerization initiator is activated by an electric field,
wherein the tube has no outlet aperture for releasing material out of the tube.

20. A method comprising:
introducing a therapeutic agent through a septum covering an inlet aperture formed at an end of a tube of an ophthalmic shunt implanted through the sclera of an eye, wherein the tube has no outlet aperture for releasing material out of the tube; and
allowing the therapeutic agent to permeate through the tube and into the eye,
wherein introducing the therapeutic agent through the septum includes piercing the septum with a needle and injecting the therapeutic agent through the needle,
after piercing the septum with the needle, activating a polymerization initiator in the septum to seal a hole formed by the needle in the septum,
wherein activating the polymerization initiator includes applying an electric field to the septum to seal a hole formed by the needle in the septum.

Assignees

• Abbott Cardiovascular Systems Inc

Inventors

• Stankus John
• Su James

Classifications

• A61F9/0017 Primary

  implantable in, or in contact with, the eye, e.g. ocular inserts · CPC title